154 related articles for article (PubMed ID: 15561831)
1. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects.
Sprandel KA; Schriever CA; Pendland SL; Quinn JP; Gotfried MH; Hackett S; Graham MB; Danziger LH; Rodvold KA
Antimicrob Agents Chemother; 2004 Dec; 48(12):4597-605. PubMed ID: 15561831
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole.
Agudelo M; Vesga O
Antimicrob Agents Chemother; 2012 May; 56(5):2659-65. PubMed ID: 22330928
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
Kang SL; Rybak MJ; McGrath BJ; Kaatz GW; Seo SM
Antimicrob Agents Chemother; 1994 Dec; 38(12):2702-9. PubMed ID: 7695250
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Palmer SM; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):701-5. PubMed ID: 8851596
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury.
Kiser TH; Hoody DW; Obritsch MD; Wegzyn CO; Bauling PC; Fish DN
Antimicrob Agents Chemother; 2006 Jun; 50(6):1937-45. PubMed ID: 16723549
[TBL] [Abstract][Full Text] [Related]
10. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole.
Sprandel KA; Drusano GL; Hecht DW; Rotschafer JC; Danziger LH; Rodvold KA
Diagn Microbiol Infect Dis; 2006 Aug; 55(4):303-9. PubMed ID: 16887471
[TBL] [Abstract][Full Text] [Related]
12. Comparative serum bactericidal activity of ceftizoxime/metronidazole, ceftizoxime, clindamycin, and imipenem against obligate anaerobic bacteria.
Kowalsky SF; Echols RM; McCormick EM
J Antimicrob Chemother; 1990 May; 25(5):767-75. PubMed ID: 2373663
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
Pea F; Di Qual E; Cusenza A; Brollo L; Baldassarre M; Furlanut M
Clin Pharmacokinet; 2003; 42(6):589-98. PubMed ID: 12793843
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics/pharmacodynamics of levofloxacin 750 mg once daily in young women with acute uncomplicated pyelonephritis.
Nicolle L; Duckworth H; Sitar D; Bryski L; Harding G; Zhanel G
Int J Antimicrob Agents; 2008 Mar; 31(3):287-9. PubMed ID: 18155885
[TBL] [Abstract][Full Text] [Related]
15. Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole.
Credito KL; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):181-3. PubMed ID: 11109019
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection.
Lewis RE; Klepser ME; Ernst EJ; Snabes MA; Jones RN
Diagn Microbiol Infect Dis; 2000 May; 37(1):51-5. PubMed ID: 10794941
[TBL] [Abstract][Full Text] [Related]
17. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.
Rodvold KA; Danziger LH; Gotfried MH
Antimicrob Agents Chemother; 2003 Aug; 47(8):2450-7. PubMed ID: 12878504
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
Frei CR; Burgess DS
Pharmacotherapy; 2005 Sep; 25(9):1161-7. PubMed ID: 16164390
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.
Benko AS; Cappelletty DM; Kruse JA; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):691-5. PubMed ID: 8851594
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults.
Cook AM; Martin C; Adams VR; Morehead RS
Antimicrob Agents Chemother; 2011 Jul; 55(7):3240-3. PubMed ID: 21576432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]